Search

everythinglearnresearchcommunity

for

Search:↓

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Some dibenzo compounds might help treat cancer with fewer side effects.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

The new platinum complexes effectively increased survival in rats with tumors, despite some reversible side effects.

Potassium iodide prevents hair loss and reduces toxicity from thallium acetate.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Thiazole, a sulfur and nitrogen chemical, is useful in creating potential drugs for conditions like seizures, cancer, bacterial infections, tuberculosis, inflammation, malaria, viruses, Alzheimer's, diabetes, and A1-receptor issues.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Adiantum capillus extract reduces pain and swelling in animals.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Hypaphorine from a fungus changes the internal structure of Eucalyptus root hairs, stopping their growth.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.